Xi'an Greday Biological Technology at CPHI China, Expanding Middle East Pharmaceutical Channels
The 21st CPHI China exhibition in Shanghai concluded successfully. Xi'an Greday Biological Technology focused on the essential-demand pharmaceutical markets of the Middle East, highlighting sterile injectable APIs and oral formulation contract manufacturing services, and engaged on-site with local pharmaceutical distributors and formulation manufacturers from Saudi Arabia, the UAE and Iraq. Following the exhibition, fixed distribution partnerships were established in Jeddah (Saudi Arabia) and Kuwait — two core regional hubs — achieving a channel breakthrough from zero to one in the Middle East and further expanding our overseas sales footprint.
The 21st CPHI China exhibition in Shanghai concluded successfully. Xi’an Greday Biological Technology focused on the essential-demand pharmaceutical markets of the Middle East, highlighting sterile injectable APIs and oral formulation contract manufacturing services, and engaged on-site with local pharmaceutical distributors and formulation manufacturers from Saudi Arabia, the UAE and Iraq. Following the exhibition, fixed distribution partnerships were established in Jeddah (Saudi Arabia) and Kuwait — two core regional hubs — achieving a channel breakthrough from zero to one in the Middle East and further expanding our overseas sales footprint.

Figure: Injectable API product line showcased at the 21st CPHI China exhibition in Shanghai
Welcome to contact us to discuss API supply and contract manufacturing cooperation.